期刊文献+

琥珀酸脱氢酶B和丙酮酸脱氢酶激酶1在鼻咽癌组织中的表达及其临床意义 被引量:2

Expressions of SDHB and PDK1 and their clinical significance in nasopharyngeal carcinoma
下载PDF
导出
摘要 目的:探讨琥珀酸脱氢酶(SDH)B和丙酮酸脱氢酶激酶(PDK)1在鼻咽癌组织中的表达及其临床意义。方法:采用免疫组化法检测78例鼻咽癌组织及35例鼻咽黏膜慢性炎症组织中SDHB和PDK1的表达情况,运用x2检验分析SDHB和PDK1表达与鼻咽癌患者临床病理因素的关系,运用Kaplan-Meter法分析其与预后的关系。结果:SDHB和PDK1在鼻咽癌组织中阳性表达率分别为39.7%(31/78)和53.8%(42/78),而在鼻咽黏膜慢性炎症组织中为62.9%(22/35)和20.0%(7/35),SDHB和PDK1表达均与鼻咽癌复发、颈部淋巴结转移相关(P<0.05),与患者性别、年龄等无显著相关(P>0.05)。K-M生存曲线提示SDHB阳性表达和PDK1阴性表达者的生存率分别高于SDHB阴性表达和PDK1阳性表达者,多因素Cox回归分析显示,T分级、临床分期、复发是影响鼻咽癌患者预后的独立因素,SDHB和PDK1表达不能作为影响鼻咽癌预后的独立因素。结论:SDHB和PDK1表达在鼻咽癌的发展、淋巴结转移、复发中起着重要作用,并可能对预后有影响,但SDHB和PDK1表达不是影响预后的独立因素。 Objective: To investigate the expressions of SDHB and PDK1 and their correlation with theclinicopathological factors and prognosis in nasopharyngeal carcinoma (NPC). Methods: Immunohistochemstry was employed to analyze the expressions of SDHB and PDK1 in 78 specimens of NPC and 35 specimens of chronic nasopharyngitis tissues (CNT). Retsults: SDHB expression detected in 39.7% of the cancer tissues was significantly lower than those in 62.9% of nasopharyngitis tissues (χ^2=5.183, P〈0.05). While PDK1 expression detected in 53.8% of the cancer tissues was significantly higher than those in 20.0% of nasopharyngitis tissues (χ^2=1 1.269, P〈0.05). SDHB and PDK1 expressions were significantly associated with lymph node metastasis, tumor recurrence, cranial nerve palsy, however, there was no significant association between the expression and gender, age. Kaplan-Meter survival analysis showed that the survival rates of positive SDHB expression and negative PDK1 expression were higher than that of negative SDHB expression and positive PDK1 expression. Multivariate Cox regression analysis showed that the development of NPC, lymph node metastasis and recurrence were independent prognostic factors for NPC, but the expressions of SDHB and PDK1 were not an independent factor. Conclusion: The expressions of SDHB and PDK1 play an important role in the development of NPC, lymph node metastasis and recurrence. SDHB and PDK1 expressions may have an impact on prognosis, but it was not independent factor affecting the prognosis in patients with NPC.
出处 《温州医学院学报》 CAS 2014年第2期91-94,共4页 Journal of Wenzhou Medical College
基金 温州市科技计划项目(Y20120022) 瑞安市科技计划项目(201203081)
关键词 鼻咽肿瘤 琥珀酸脱氢酶B 丙酮酸脱氢酶激酶1 临床病理 预后 nasopharyngeal neoplasms succinate dehydrogenase subunit B pyruvate dehydrogenase kinase 1 immunohistochemistry prognosis
  • 相关文献

参考文献12

  • 1Fishbein L, Merrill S, Fraker DL, et al. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing[J]. Ann Surg Oncol, 2013, 20(5): 1444-1450.
  • 2van Hulsteijn LT, Dekkers OM, Hes FJ, et al. Risk of malig- nant paraganglioma in SDHB-mutation and SDHD-muta- tion carriers: a systematic review and meta-analysis[J]. J Med Genet, 2012, 49(12): 768-776.
  • 3Patterson E, Webb R, Weisbrod A, et al. The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma[J]. Endocr Relat Cancer, 2012, 19(2): 157-166.
  • 4Yang C, Matro JC, Huntoon KM, et al. Missense mutations in the human SDHB gene increase Protein degradation with- out altering intrinsic enzymatic function[J]. FASEB J, 2012, 26(11): 4506-4516.
  • 5Matro J, Giubellino A, Pacak K. Current and future thera- peutic approaches for metastatic pheochromocytoma and paraganglioma: focus on SDHB tumors[J]. Horm Metab Res, 2013, 45(2): 147-153.
  • 6Fujiwara S, Kawano Y, Yuki H, et al. PDK1 inhibition is a novel therapeutic target in multiple myeloma[J]. Br J Cancer, 2013, 108(1): 170-178.
  • 7Hur H, Xuan Y, Kim YB, et al. Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential thera- peutic target[J]. Int J Oncol, 2013, 42(1): 44-54.
  • 8Peifer C, Alessi DR. New anti-cancer role for PDK1 inhibitors: preventing resistance to tamoxifen[J]. Biochem J, 2009, 417(1): 5-7.
  • 9Wigfield SM, Winter SC, Giatromanolaki A, et al. PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer[J]. Br J Cancer, 2008, 98(12): 1975-1984.
  • 10Yu J, Chen KS, Li YN, et al. Silencing of PDK1 gene expres- sion by RNA interference suppresses growth of esophageal cancer[J]. Asian Pac J Cancer Prev, 2012, 13(8): 4147- 4151.

二级参考文献23

  • 1罗京伟,徐国镇.鼻咽癌治疗的进展[J].中华耳鼻咽喉科杂志,2004,39(8):509-512. 被引量:47
  • 2李桂源,周鸣,刘华英.鼻咽癌遗传学研究进展[J].中国肿瘤,2006,15(12):797-803. 被引量:6
  • 3刘仲奇,田勇泉,刘俊秀,张迎宏,马芙蓉,胡永芳.染色体分离基因在纯化鼻咽癌组织中的表达[J].中国耳鼻咽喉头颈外科,2007,14(4):195-198. 被引量:1
  • 4Cai J, Parr C, Watkins G, et al. Decreased pigment epithelium derived factor expression in human breast cancer progression. Clin Cancer Res, 2006, 12:3510-3517.
  • 5Cho S, Ko HM, Kim JM , et al. Positive regulation of apoptosis signal-regulating kinase 1 by hD53L1. J Biol Chem, 2004, 279: 16050 - 16056.
  • 6Gohring B, Holzhansen HI, Meye A, et al. Endopeptidase 24. 11/CD10 is down-regulated in renal cell cancer. Int J Mol Med, 1998, 2:409-414.
  • 7Rocken C, Carl-McGrath S, Grontzdsrffer I, et al. Ectopeptidases are differentially expressed in hepatocellular carcinomas. Int J Oncol, 2004, 24:487-495.
  • 8Simpson A J, Wallace WA, Marsden ME, et al. Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection. J Immunol, 2001,167 : 1778-1786.
  • 9Xie L, Palmsten K, MacDonald B, et al. Basement membranederived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth. Exp Biol Med ( Maywood ) , 2008, 233 : 155-162.
  • 10Funakoshi S, Ezaki T, Kong J, et al. Repression of the desmocollin 2 gene expression in human colon cancer cells is relieved by the homeodomain transcription factors Cdxl and Cdx2. Mol Cancer Res, 2008, 6 : 1478-1490.

共引文献5

同被引文献20

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部